Journal CME/HeartRhythm Vol. 13, Issue 5 - Drug Induced Brugada Syndrome: Clinical Characteristics and Risk Factors
Journal CME
Faculty
OVERVIEW
Journal CME/HeartRhythm Vol. 13, Issue 5 - Drug Induced Brugada Syndrome: Clinical Characteristics and Risk Factors is organized by Heart Rhythm Society (HRS) and would be held during Apr 10, 2016 - May 01, 2018.
The target audience for this medical event for all clinical cardiac electrophysiologists who take care of patients with cardiac arrhythmias. In addition, students, residents, researchers, all cardiologists and other medical professional who prescribe drugs to patients will find this activity beneficial.This CME Conference has been approved with a maximum of 1 AMA PRA Category 1 Credit.
Course Description:
Cardiac arrest may result from seemingly innocuous medications that do not necessarily have cardiac indications. The best-known example is the drug-induced long QT syndrome. A less known, but not necessarily less important form of drug-induced proarrhythmia is the drug-induced Brugada-syndrome. We aimed to identify clinical and electrocardiographic risk markers for drug-induced Brugada syndrome.
Additional details will be posted as soon as they are available.